Trulieve Cannabis Corp. TRLV
10.33 USD -0.57 (-5.23%)
Regular-session close
10.76 +0.43 +4.21%
After hours · Nov 16, 4:25 PM ET
10.32 Day range 11.14
4.62 52-week range 13.28
- YTD
- +18.87%
- 1 year
- +90.59%
News
gurufocus.com Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida Trulieve to Open Medical Cannabis Dispensary in Tampa, FloridaPR NewswireTALLAHASSEE, Fla., Nov. 16, 2026New Hillsborough County location will host grand openin
prnewswire.com Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced…
prnewswire.com Trulieve Announces November 2026 Event Participation TALLAHASSEE, Fla., Nov. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced…
defenseworld.net Trulieve Cannabis Q3 Earnings Call Highlights Trulieve Cannabis (NYSE: TRLV) reported third-quarter revenue of $230 million, up 4% from both a year earlier and the prior quarter on a medical-only basis, as growth in Georgia and Pennsylvania…
prnewswire.com Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia New Trulieve-branded kiosk offers qualified patients product access, education, and personalized guidance TALLAHASSEE, Fla., Nov. 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV)…benzinga.com Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.05 by 80 percent. The company reported quarterly sales of $230.000 million…
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
benzinga.com Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for…
benzinga.com Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures fell, led by Deckers down 9% after mixed results and reduced FY27 guidance. BayCom, ROLR, Trulieve and others also slid premarket.benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
